TSMDA: Target and symptom-based computational model for miRNA-disease-association prediction. (2021)
Attributed to:
Newton001 Understanding Antimicrobial Resistance Mutations in Tuberculosis: Towards Personalised Treatment to Combat Multi-drug Resistance
funded by
Newton Fund
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.omtn.2021.08.016
PubMed Identifier: 34631283
Publication URI: http://europepmc.org/abstract/MED/34631283
Type: Journal Article/Review
Volume: 26
Parent Publication: Molecular therapy. Nucleic acids
ISSN: 2162-2531